AstraZeneca

COVID-19

AstraZeneca is distributing a viral vector-based COVID-19 vaccine product in Canada and other countries called ChAdOx1 nCoV-19. It is marketed in Canada as Vaxzevria.1)

Affiliations

AstraZeneca was a founding member of the Alliance for a Stronger FDA.2)

AstraZeneca is a member organization of the World Economic Forum.3)

Acquisitions

AstraZeneca acquired Alexion in 2021, adding its rare disease brand to the company's portfolio.4)

Payments from AstraZeneca

The following is a developing list of individuals and organizations that AstraZeneca has given money to related to the COVID-19 pandemic:

Payments to Individuals

Name Type Amount Description
David Fisman Honorarium Unknown Honorarium paid for advisory board meetings regarding COVID-19 related projects.5)
Kyla Hildebrand Research Unknown Research funding for allergy study6)

Payments to Organizations

Name Type Amount Description
St. Michaels Hospital Foundation Donation $1,000,000.00 - $2,499,999.00 Lifetime donations.7)
University Hospitals Kingston Foundation Donation $50,000.00 – $99,999.00 Cumulative donations up to December 31, 2019.8)
1)
Health Canada. (2021, November 23). AstraZeneca Vaxzevria COVID-19 vaccine. Government of Canada. Retrieved December 5, 2021, from https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/astrazeneca.html
2)
AstraZeneca Calls for FDA Funding Increase. (2010, September 20). Pharmaceutical Technology. https://web.archive.org/web/20220817001606/https://www.pharmaceutical-technology.com/uncategorized/news96475-html/
3)
AstraZeneca. (2021, December 3). World Economic Forum. https://archive.ph/CV1XD
4)
Kemp, A. (2021, July 21). Acquisition of Alexion completed. AstraZeneca. https://archive.ph/c5apv
5)
Fisman, D. (2021). Declaration of Interest. Ontario COVID-19 Science Advisory Table. https://covid19-sciencetable.ca/wp-content/uploads/2020/10/Declaration-of-Interest_Science-Table_David-Fisman2.pdf
6)
Chan, E. S., Abrams, E. M., Hildebrand, K. J., & Watson, W. (2018). Early introduction of foods to prevent food allergy. Allergy, Asthma & Clinical Immunology, 14(S2). https://doi.org/10.1186/s13223-018-0286-1
7)
St. Michael’s Foundation 2020/21 Annual Report. (2021). FlippingBook. https://online.flippingbook.com/view/383454962/40/
8)
Recognizing your contribution. University Hospitals Kingston Foundation. Retrieved February 21, 2022, from https://www.uhkf.ca/Your-Impact/Recognizing-Your-Contribution
Print/export